Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild, Moderate, or Severe Alzheimer's Disease”

2 trials

Showing 2 of 2 results

Testing effectiveness (Phase 2)Looking for participantsNCT06745583
What this trial is testing

Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

Who this might be right for
Mild, Moderate, or Severe Alzheimer's Disease
Elixiron Immunotherapeutics (Hong Kong) Ltd. 15
Not applicableStudy completedNCT01081743
What this trial is testing

Effectiveness of Care Management in Alzheimer Patients

Who this might be right for
Alzheimer Disease or Associated DisorderMild to Moderately Severe Dementia
Institut de Sante Publique, d'Epidemiologie et de Developpement 270

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation